COPYRIGHT LICENSE: for use in paper or pdf format of the Adult or Adolescent Sheehan-Homicidality Tracking Scale Clinically Meaningful Change Measure Version (S-HTS CMCM)
Dr. Ivan Sascha Sheehan and Dr. David V Sheehan as “copyright holders” of the “Sheehan-Homicidality TrackingScale, Clinically Meaningful Change Measure Version(S-HTS CMCM)” hereinafter referred to as the “S-HTS CMCM”, hereby grant permission to XXXXXXXX, a pharmaceutical company conducting international clinical drug development or a clinical research organization or a healthcare provider, to use the S-HTS CMCM under the following terms and conditions:
Dr. Ivan Sascha Sheehan and Dr. David V. Sheehan, hereby grantpermission to XXXXXXXX as sponsor of the clinical trials / clinical research organization / provider of healthcare, defined in Appendix 1 hereinafter, and to XXXXXXXX’s affiliated companies and subcontractors / clinical care setting, ONLY for the purpose of implementing such research studies / provision of care, defined hereinafter:
-the right to reproduce in paper format and in pdf format, but not in electronic or computer format the S-HTS CMCM and its existing and future translations and to use it within its domestic and international clinical trials / your clinical care setting, upon individual request for each trial and number of uses in each trial;
-the right to use the translations of the S-HTS CMCM,in the translationsapproved by the copyright holders, in collaboration with MAPI,for each trial as requested; MAPI Language Services is the exclusive coordinating center to ensure the production of consistent and conceptually equivalent translations of the S-HTS CMCMand to provide linguistic validation and certification of these translations and should be contacted directly for this purpose. MAPI Language Services may charge its own usual fees for this work.
Marie-Sidonie Edieux
MAPI Research Trust
27 Rue de la Villette
69003 Lyon France
tel: +33 (0)4 72 13 66 67
fax: +33 (0)4 72 13 66 68/:+33 (0)4 72 13 69 50
-the unrestricted right to use all data and results generated from the use of the S-HTS CMCM in domestic and international clinical trials / your clinical care setting.
-the right to use the S-HTS CMCMin rater training.
Such granting of rights to XXXXXXXX, its affiliated companies and subcontractors / your clinical care setting, to use the S-HTS CMCM and its final translations, as hereinabove provided for, shall be free of charge.
In consideration of this granting of rights, XXXXXXXX, its affiliated companies and subcontractors / your clinical care setting, undertake to comply with the following conditions:
-XXXXXXXX, its affiliated companies and subcontractors / your clinical care setting, undertake to include on any reproduction of the S-HTS CMCM, used within clinical trials / provision of healthcare, defined hereinafter, a mention redacted as follows:
© Copyright 2005-2017Sheehan IS, Sheehan DV. All rights reserved.
May be reproduced only with the permission of Dr. Ivan Sascha Sheehan or Dr. David V. Sheehan, copyright holders. For permission contact or
-XXXXXXXX, its affiliated companies and subcontractors / your clinical care setting, undertake to transmit to Dr. Ivan Sascha Sheehan or Dr. David V. Sheehana copy of ANY and ALL final translations of the S-HTS CMCM, in Microsoft Word and/or PDF format.
-In any publication resulting from the use of the S-HTS CMCM, XXXXXXXX, its affiliated companies and subcontractors / your clinical care setting, SHALL NOT reproduce any part of the S-HTS CMCM, or its translations, without the prior written consent of Dr. Ivan Sascha Sheehan or Dr. David V. Sheehan, copyright holders.
-The recommended citations for the S-HTS CMCM are:
- Sheehan, Ivan Sascha. "Are suicide terrorists suicidal? A critical assessment of the evidence." Innovations in clinical neuroscience 11.9-10 (2014): 81-92.
- Sheehan IS. Professor Sheehan. Sheehan Research Scales. Retrieved December 12, 2016 from
It is hereby agreed that, except as otherwise set forth herein, no other right or license for use of theS-HTS CMCMshall be granted to XXXXXXXX, its affiliated companies and subcontractors / your clinical care setting, as a result of this license agreement,and that the rights attached to the S-HTS CMCMand its translations shall remain the exclusive property of Dr. Ivan Sascha SheehanandDr. David V. Sheehan, copyright holders.
Please indicate your approval of the terms of this agreement by returning your completed and signed version of this agreement to Dr. Ivan Sascha Sheehan or Dr. David V. Sheehanat . Dr. Ivan Sascha Sheehan or Dr. David V. Sheehanwill countersign this agreement on behalf of the copyright holders, and return it to you directly by email. If you make any changes to this agreement, use track changes in MS Word. Any such changes will be reviewed, and if acceptable, will be countersigned signed by one of the copyright holders, or amended further, and returned to you.
Agreed and accepted:
______
Signature of Dr. Ivan Sascha Sheehan, copyright holder orDate
Signature of Dr. David V. Sheehan, copyright holder
For XXXXXX, the sponsoring company / CRO / healthcare provider / clinical care setting, requesting permission:
______
SignatureDate
Print Name and Title: XXXXXX
Phone: XXXXXXXXX
E-mail: XXXXXXXXXX
APPENDIX 1
Clinical trials specific to this permission request are defined below.
Permission has been granted to XXXXXXXX, its affiliated companies and subcontractors / a health care provider, to use the S-HTS CMCM, as designated by the terms mentioned above and signed by Dr. Ivan Sascha Sheehan or Dr. David V. Sheehan as copyright holders, for the following clinical trials / clinical care setting ONLY, until further request and permission has been granted for studies not listed hereinafter:
Row / Product/Compound /Study Identification Number
/Projected number to be randomized to all study medications at baseline visit per protocol / clinical care setting
1 / XXXXX / XXXXX / XXXProjected number of times S-HTS CMCMwill be used in your study / clinical care setting
2 / XX
Budget for Study being conducted using the S-HTS CMCM at no cost*:
US $______ / Projected number of S-HTS CMCM administrations in your study / clinical care setting
(Row 1 above X Row 2 above)
3 / XXXX
______
Signature of Dr. Ivan Sascha Sheehan, copyright holder orDate
Signature of Dr. David V. Sheehan, copyright holder
Non-Profit settings:
Individual researchers, clinicians and students, working in nonprofit or publicly owned settings, (including universities, nonprofit hospitals, and government institutions), may make paper copies of the S-HTS CMCMfor their own personal clinical and research use, but not for institutional use.
In these settings the S-HTS CMCMmay be reproduced in paper format and in PDF format, but may not be computerized in these settings without written permission from Dr. Ivan Sascha Sheehan or Dr. David V. Sheehan. The S-HTS CMCMmay not be posted on any institution’s website. Any use involving financial gain requires a license agreement signed by a copyright holder and payment of a per use licensing fee.
* Any use of the S-HTS CMCM in a research study with a budget above US $50,000, and which involves bringing in overhead to the participating institution, requires a license agreement signed by the copyright holder and payment of a per use licensing fee.
For-Profit settings:
The use of the S-HTS CMCM for any “for profit” use or in any “for profit” setting is not free and requires a license agreement signed by the copyright holder and payment of a per use licensing fee. In “for profit” settings no part of the S-HTS CMCMmay be reproduced or transmitted in any form, or by any means, electronic or mechanical, including photocopying, or by any information storage or retrieval system, without written permission from Dr. Ivan Sascha Sheehan or Dr. David V. Sheehan.
The S-HTS CMCMmay not be computerized without written permission from Dr. Ivan Sascha Sheehan or Dr. David V. Sheehan.
For permission contact